StemGen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2014 | -122.76K | 0 | 122K |
|---|---|---|---|
| 2015 | -107.41K | -35K | 142.33K |
| 2016 | -451.80K | 0 | 452.43K |
| 2017 | 7.54K | 0 | 0 |
| 2018 | -8.13K | 0 | 7.5K |
| 2019 | -105.09K | 0 | 87.81K |
| 2020 | -36.52K | 0 | 34.01K |
| 2021 | -141.19K | 22.5K | 119.80K |
| 2022 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 |
SGNI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 1.34K | 236 | 2.75K | 20.02K | 635 | 635 | 0 | 80 | 840 |
Operating activities | ||||||||||
Net income | 0 | 0 | -433.14K | -230.77K | -425.51K | 6.11K | -70.00K | -599.83K | -491.99K | 16.42K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 112.47K | 19.37K | 60K | 8.22K | 0 | 0 | 1.57K | 23.09K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 68.67K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 68.67K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 10K | -10K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 171.6K | 122K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | -26.54K | 15.97K | 66.36K | 24.19K | 0 | -110.57K | 221.66K | -46.72K |
Cash generated by operating activities | 0 | 0 | -141.19K | -36.52K | -105.09K | -8.13K | 7.54K | -451.80K | -107.41K | -122.76K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 22.5K | 0 | 0 | 0 | 0 | 0 | -35K | 0 |
Cash generated by investing activities | 0 | 0 | 22.5K | 0 | 0 | 0 | 0 | 0 | -35K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 7K | 21.6K | 0 | 0 | 0 | 19.5K | 297K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 122.83K | 0 |
Cash used in financing activities | 0 | 0 | 119.80K | 34.01K | 87.81K | 7.5K | 0 | 452.43K | 142.33K | 122K |
Net Change In Cash | 0 | 0 | 1.10K | -2.51K | -17.27K | -635 | 0 | 635 | -80 | -760 |
Cash at end of period | 0 | 1.34K | 1.34K | 236 | 2.75K | 0 | 635 | 635 | 0 | 80 |
| Data source | Data source | Data source | Data source | Data source | Data source |